Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahiro Takeuchi

Showing results (51-60 of 187) with videos related to

Pageof 19
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|June 27, 2013
Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trialYoshikuni Mizuno, Masahiro Nomoto, Tomoyoshi Kondo, et al.
British Journal of Clinical Pharmacology|February 9, 2019
Population/regional differences in efficacy of 3 drug categories (antidiabetic, respiratory and psychotropic agents) among East Asians: A retrospective study based on multiregional clinical trialsKimie Sai, Akiomi Yoshida, Tadaaki Hanatani, et al.
The Journal of Rheumatology|February 17, 2007
High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritisShigeki Momohara, Hiroshi Okamoto, Takuji Iwamoto, et al.
Journal of Neurology|July 16, 2014
Transdermal rotigotine in advanced Parkinson's disease: a randomized, double-blind, placebo-controlled trialMasahiro Nomoto, Yoshikuni Mizuno, Tomoyoshi Kondo, et al.
Targeted Oncology|October 31, 2021
Phase II Study of Third-Line Panitumumab Rechallenge in Patients with Metastatic Wild-Type KRAS Colorectal Cancer Who Obtained Clinical Benefit from First-Line Panitumumab-Based Chemotherapy: JACCRO CC-09Akihito Tsuji, Masato Nakamura, Takanori Watanabe, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 7, 2023
Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 studyYasuhiro Kodera, Kazuhiro Yoshida, Mitsugu Kochi, et al.
Breast Cancer Research and Treatment|October 26, 2006
Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapyKan Yonemori, Noriyuki Katsumata, Masayuki Kaneko, et al.
Circulation Reports|March 11, 2021
Japan Heart Failure Model　- Derivation and Accuracy of Survival Prediction in Japanese Heart Failure PatientsShigeru Miyagawa, Kyongsun Pak, Shungo Hikoso, et al.
Oncology and Therapy|October 9, 2021
<sup>18</sup>F-FDG-PET/CT as an imaging biomarker for regorafenib efficacy in metastatic colorectal cancer (JACCRO CC-12)Masato Nakamura, Hironaga Satake, Tamotsu Sagawa, et al.
The Oncologist|July 15, 2009
Factors that affect the duration of the interval between the completion of palliative chemotherapy and deathKenji Hashimoto, Kan Yonemori, Noriyuki Katsumata, et al.
Pageof 19

Showing results (51-60 of 187) with videos related to

Sort By:
Pageof 19
Movement Disorders : Official Journal of the Movement Disorder Society|June 27, 2013
Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trialYoshikuni Mizuno, Masahiro Nomoto, Tomoyoshi Kondo, et al.
British Journal of Clinical Pharmacology|February 9, 2019
Population/regional differences in efficacy of 3 drug categories (antidiabetic, respiratory and psychotropic agents) among East Asians: A retrospective study based on multiregional clinical trialsKimie Sai, Akiomi Yoshida, Tadaaki Hanatani, et al.
The Journal of Rheumatology|February 17, 2007
High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritisShigeki Momohara, Hiroshi Okamoto, Takuji Iwamoto, et al.
Journal of Neurology|July 16, 2014
Transdermal rotigotine in advanced Parkinson's disease: a randomized, double-blind, placebo-controlled trialMasahiro Nomoto, Yoshikuni Mizuno, Tomoyoshi Kondo, et al.
Targeted Oncology|October 31, 2021
Phase II Study of Third-Line Panitumumab Rechallenge in Patients with Metastatic Wild-Type KRAS Colorectal Cancer Who Obtained Clinical Benefit from First-Line Panitumumab-Based Chemotherapy: JACCRO CC-09Akihito Tsuji, Masato Nakamura, Takanori Watanabe, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 7, 2023
Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 studyYasuhiro Kodera, Kazuhiro Yoshida, Mitsugu Kochi, et al.
Breast Cancer Research and Treatment|October 26, 2006
Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapyKan Yonemori, Noriyuki Katsumata, Masayuki Kaneko, et al.
Circulation Reports|March 11, 2021
Japan Heart Failure Model　- Derivation and Accuracy of Survival Prediction in Japanese Heart Failure PatientsShigeru Miyagawa, Kyongsun Pak, Shungo Hikoso, et al.
Oncology and Therapy|October 9, 2021
<sup>18</sup>F-FDG-PET/CT as an imaging biomarker for regorafenib efficacy in metastatic colorectal cancer (JACCRO CC-12)Masato Nakamura, Hironaga Satake, Tamotsu Sagawa, et al.
The Oncologist|July 15, 2009
Factors that affect the duration of the interval between the completion of palliative chemotherapy and deathKenji Hashimoto, Kan Yonemori, Noriyuki Katsumata, et al.
Pageof 19